Form D · Biotechnology
Boundless Bio, Inc.
San Diego, CA · CIK 0001782303
Offering snapshot reported Aug 15, 2023 · SEC filing
- Reported sold
- $100M Offering amount: $100M
- Investors reported
- 26 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 5, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 15, 2023 | Initial | $100,000,000 | No comparison | 26 | SEC filing |
| May 4, 2021 | Initial | $105,585,007 | No comparison | 28 | SEC filing |
| Mar 12, 2020 | Initial | $23,232,507 | No comparison | 23 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-489721
Source: Form D, filed Aug 15, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Christine Brennan, Ph.D. | Director |
| Kristina Burow | Director |
| Ho Sung Cho, Ph.D. | Director |
| Jason Christiansen, Ph.D. | Director |
| Benjamin Cravatt, Ph.D. | Director |
| Chris Hassig, Ph.D. | Director |
| Zachary D. Hornby | Director, Executive |
| Jennifer Lew | Director |
| Jonathan Lim, M.D. | Director |
| Jakob Loven, Ph.D. | Director |
| Scott Moorefield, Ph.D. | Director |
| Carolyn Ng, Ph.D. | Director |
| Fabio Pucci, Ph.D. | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
9880 Campus Point Drive Suite 120
San Diego, CA, 92121
San Diego, CA, 92121